Lucid Diagnostics Q4 EPS $(0.23) Beats $(0.26) Estimate, Sales $1.04M Miss $1.05M Estimate
Lucid Diagnostics Q4 EPS $(0.23) Beats $(0.26) Estimate, Sales $1.04M Miss $1.05M Estimate
Lucid Diagnostics第四季度每股收益美元（0.23美元）超过预期（0.26美元），销售额为104万美元，低于105万美元的预期
Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.26) by 11.54 percent. This is a 53.33 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $1.04 million which missed the analyst consensus estimate of $1.05 million by 0.95 percent. This is a 828.57 percent increase over sales of $112.00 thousand the same period last year.
Lucid Diagnostics（纳斯达克股票代码：LUCD）公布的季度亏损为每股0.23美元，比分析师普遍预期的0.26美元（0.26美元）高出11.54％。这比去年同期每股亏损0.15美元（0.15美元）下降了53.33％。该公司公布的季度销售额为104万美元，比分析师普遍预期的105万美元低0.95％。这比去年同期的11.2万美元的销售额增长了828.57％。